Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Huashan Biochemicals is a specialized Chinese pharmaceutical company focused on the production of animal-derived active pharmaceutical ingredients (APIs) and biochemical intermediates. Established in 1994 and headquartered in Qingdao, the company operates large-scale extraction and purification facilities that comply with international GMP standards. Their core product portfolio includes Heparin Sodium, Chondroitin Sulfate, Bilirubin, and various digestive enzymes such as Pepsin and Pancreatin. As a significant exporter, the company serves the global pharmaceutical, nutraceutical, and diagnostic industries. Their expertise lies in the complex processing of biological tissues to provide high-purity raw materials for cardiovascular, musculoskeletal, and gastrointestinal health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Huashan Biochemicals.